Radioprotection by short-term oxidative preconditioning: Role of manganese superoxide dismutase

Department of Environmental and Occupational Health, University of Pittsburgh, Pittsburgh, PA 15219, USA.
FEBS letters (Impact Factor: 3.17). 10/2009; 583(21):3437-42. DOI: 10.1016/j.febslet.2009.10.013
Source: PubMed


Manganese superoxide dismutase (MnSOD) is vital to the protection of mitochondria and cells against oxidative stress. Earlier, we demonstrated that catalytically active homo-tetramer of MnSOD can be stabilized by oxidative cross-linking. Here we report that this effect may be translated into increased radioresistance of mouse embryonic cells (MECs) by pre-exposure to oxidative stress. Pre-treatment of MECs with antimycin A, rotenone or H(2)O(2) increased their survival after irradiation. Using MnSOD siRNA, we show that MECs with decreased MnSOD levels displayed a lowered ability to preconditioning. Thus oxidative preconditioning may be used for targeted regulation of MnSOD.


Available from: Natalia Belikova
  • Source
    • "The concept of using MnSOD transgene expression for radiation protection followed upon studies in which MnSOD was demonstrated to be one of the rapid upregulated cellular response products to ionizing irradiation in tissues (Epperly et al., 1998, 1999a,b; Greenberger, 2008, 2009; Belikova et al., 2009b). The concept of developing MnSOD–PL was based on radiobiology studies demonstrating that the MnSOD transgene product was uniquely mitochondrially localized (SOD2) compared to the cytoplasmic superoxide dismutase (SOD1) or extracellular SOD3 (Epperly et al., 2003e). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Mitochondrial targeted radiation damage protectors (delivered prior to irradiation) and mitigators (delivered after irradiation, but before the appearance of symptoms associated with radiation syndrome) have been a recent focus in drug discovery for (1) normal tissue radiation protection during fractionated radiotherapy, and (2) radiation terrorism counter measures. Several categories of such molecules have been discovered: nitroxide-linked hybrid molecules, including GS-nitroxide, GS-nitric oxide synthase inhibitors, p53/mdm2/mdm4 inhibitors, and pharmaceutical agents including inhibitors of the phosphoinositide-3-kinase pathway and the anti-seizure medicine, carbamazepine. Evaluation of potential new radiation dose modifying molecules to protect normal tissue includes: clonogenic radiation survival curves, assays for apoptosis and DNA repair, and irradiation-induced depletion of antioxidant stores. Studies of organ specific radioprotection and in total body irradiation-induced hematopoietic syndrome in the mouse model for protection/mitigation facilitate rational means by which to move candidate small molecule drugs along the drug discovery pipeline into clinical development.
    Frontiers in Oncology 01/2011; 1:59. DOI:10.3389/fonc.2011.00059
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Radiation therapy occupies an important position in the treatment of malignant diseases in spite of the existence of radiation side effects on normal tissues. Thus, substances are being developed which are designed to reduce both the acute and long term radiation effects on healthy tissues. Currently a sulphur-containing compound amifostine (WR2721, ethyol) is used in clinical practice as a radioprotectant. However, it itself has considerable side effects including hypotension (found in 62% of patients), hypocalcaemia, diarrhoea, nausea, and vomiting. Carbon nanospheres, known as fullerenes, and their water soluble derivatives (e.g. C 60 (OH) 24 , dendrofullerene DF-1) exert anti-oxidative properties and reduce damage to the DNA in irradiated cells. Water soluble fullerenes are low-toxic substances and thus, are attractive in terms of their use as radioprotectants.
    Journal of applied biomedicine 01/2012; 10(1). DOI:10.2478/v10136-012-0002-2 · 1.30 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Butin (7,3',4'-trihydroxydihydroflavone), a flavonoid with antioxidant activity, was recently reported to protect cells against H2O2-induced apoptosis, oxidative DNA damage and oxidative mitochondrial dysfunction. The objective of the present study was to elucidate the mechanism by which butin protects mitochondria. The antioxidant function of manganese superoxide dismutase (Mn SOD) is important in preventing oxidative stress. While exposure to H2O2 reduced the expression of Mn SOD in Chinese hamster lung fibroblast (V79-4), the addition of butin restored Mn SOD expression at both the mRNA and protein levels, resulting in increased Mn SOD activity. The transcription factor NF-E2-related factor 2 (Nrf2) regulates Mn SOD gene expression by binding to the antioxidant responsive element (ARE). Butin enhanced the nuclear translocation and ARE-binding activity of Nrf2, which was decreased by H2O2. The siRNA-mediated knockdown of Nrf2 attenuated butin-induced Mn SOD expression and activity. Further, phosphatidylinositol 3-kinase (PI3K)/protein kinase B (PKB, Akt) contributed to the ARE-driven Mn SOD expression. Butin activated PI3K/Akt and exposure to either LY294002 (a PI3K inhibitor), Akt inhibitor IV (an Akt-specific inhibitor), or Akt siRNA suppressed the butin-induced activation of Nrf2, resulting in decreased Mn SOD expression and activity. Finally, the cytoprotective effect of butin against H2O2-induced cell damage was suppressed by the siRNA-mediated knockdown of Mn SOD. These studies demonstrate that butin attenuates oxidative stress by activating Nrf2-mediated Mn SOD induction via the PI3K/Akt signaling pathway.
    Journal of Cellular Biochemistry 06/2012; 113(6):1987-97. DOI:10.1002/jcb.24068 · 3.26 Impact Factor
Show more